In 2016, Agnihotri et al. published the finding of a frequently recurrent in-frame fusion between the SH3PXD2A and HTRA1 genes in 12/125 (10%) of their schwannoma patients, including 7/64 (11%) of their VS patients [10]. This evidence concerns the gene SH3PXD2A and schwannoma.